Western blot analysis using anti-Sirtuin 2 (human), pAb (Prod. No. AG-25A-0083) at 1:4000 dilution. 1: Human Sirtuin 2 (His-tagged). 2: Human FGF21 (His-tagged) (negative control).
anti-Sirtuin 2 (human), pAb
AG-25A-0083
ApplicationsWestern Blot, ELISA
Product group Antibodies
ReactivityHuman
TargetSIRT2
Overview
- SupplierAdipoGen Life Sciences
- Product Nameanti-Sirtuin 2 (human), pAb
- Delivery Days Customer10
- Antibody SpecificityRecognizes human sirtuin 2. Detects a band of ~45kDa by Western blot.
- ApplicationsWestern Blot, ELISA
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- FormulationLiquid
- Gene ID22933
- Target nameSIRT2
- Target descriptionsirtuin 2
- Target synonymsNAD-dependent deacetylase sirtuin-2; NAD-dependent protein deacetylase sirtuin-2; regulatory protein SIR2 homolog 2; silent information regulator 2; SIR2; SIR2L; SIR2L2; SIR2-like protein 2; sir2-related protein type 2; sirtuin type 2
- HostRabbit
- Protein IDQ8IXJ6
- Protein NameNAD-dependent protein deacetylase sirtuin-2
- Scientific DescriptionPolyclonal Antibody. Recognizes human sirtuin 2. Detects a band of ~45kDa by Western blot. Source: Rabbit. Applications: ELISA, WB. Liquid. 0.2microm-filtered solution in PBS, pH 7.4. Contains no preservatives. Sirtuin-2 is a NAD-dependent protein deacetylase, which deacetylates the Lys-40 of a-tubulin. It is involved in the control of mitotic exit in the cell cycle. Furthermore, a variety of age-associated diseases such as type 2 diabetes, obesity, osteoporosis, and Alzheimers disease are associated with sirtuins. Selective inhibition of Sirtuin-2 achieves neuroprotection and identifies Sirtuin-2 to be a potential therapeutic avenue in Huntingtons and Parkinsons disease. - Sirtuin-2 is a NAD-dependent protein deacetylase, which deacetylates the Lys-40 of a-tubulin. It is involved in the control of mitotic exit in the cell cycle. Furthermore, a variety of age-associated diseases such as type 2 diabetes, obesity, osteoporosis, and Alzheimers disease are associated with sirtuins. Selective inhibition of Sirtuin-2 achieves neuroprotection and identifies Sirtuin-2 to be a potential therapeutic avenue in Huntingtons and Parkinsons disease.
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203